Shalini Sharp Insider Trading
Get free email notifications about insider trading for Shalini Sharp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shalini Sharp. Shalini Sharp is a Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and a CFO in AGENUS INC ($AGEN) and a Director in AGENUS INC ($AGEN) and a in ARRAY BIOPHARMA INC ($ARRY) and a Director in ARRAY BIOPHARMA INC ($ARRY) and a Director in SUTRO BIOPHARMA, INC. ($STRO) and an CFO & Executive Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and a CFO & Senior Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and a EVP, Finance in Ultragenyx Pharmaceutical Inc. ($RARE) and a in Mirati Therapeutics, Inc. ($MYG) and a Director in Nuvation Bio Inc. ($PANA) and a Director in Organon & Co. ($OGN).
Address: C/O ANTIGENICS INC. 630 FIFTH AVE., SUITE 2100 NEW YORK 10111 NY
Companies in which Shalini Sharp is an Insider
AGENUS INC
Trading Symbol: AGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Shalini Sharp: Director, CFO
Holdings: 104,270 shares
Current Value: $416,037
Latest Transaction: Jun 22 2018
$AGEN Market Capitalization: $345.02M
$AGEN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARRAY BIOPHARMA INC
Trading Symbol: ARRYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp: Director
Holdings: 5,000 shares
Current Value: $52,650
Latest Transaction: Jul 30 2019
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Trading Symbol: MYGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp:
Holdings: 2,424 shares
Latest Transaction: Mar 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROCRINE BIOSCIENCES INC
Trading Symbol: NBIXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Shalini Sharp: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 20 2021
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nuvation Bio Inc.
Trading Symbol: NUVBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp: Director
Holdings: 25,000 shares
Latest Transaction: Feb 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Organon & Co.
Trading Symbol: OGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SUTRO BIOPHARMA, INC.
Trading Symbol: STROIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Shalini Sharp: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Trading Symbol: RAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp: EVP, Finance, CFO & Executive Vice President, CFO & Senior Vice President
Holdings: 97,812 shares
Current Value: $7,131,473
Latest Transaction: Oct 16 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Shalini Sharp
Sentiment: All, AGEN, ARRY, MYG, NBIX, NUVB, OGN, STRO, RARE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | OGN | Organon & Co. | Sharp Shalini | Director | Option Exercise | A | 0.00 | 9,061 | 0 | 9,061 | |
May 20 2021 | NBIX | NEUROCRINE BIOSCIE ... | Sharp Shalini | Director | Option Exercise | A | 92.35 | 8,833 | 815,728 | 8,833 | |
Mar 30 2021 | MYG | Mirati Therapeutic ... | Sharp Shalini | Option Exercise | A | 164.98 | 3,523 | 581,225 | 3,523 | ||
Mar 30 2021 | MYG | Mirati Therapeutic ... | Sharp Shalini | Grant | A | 0.00 | 2,424 | 0 | 2,424 | 0 to 2.4 K | |
Feb 26 2021 | PANA | Nuvation Bio Inc. | Sharp Shalini | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Feb 26 2021 | PANA | Nuvation Bio Inc. | Sharp Shalini | Director | Grant | A | 10.00 | 10,000 | 100,000 | 35,000 | 25 K to 35 K (+40.00 %) |
Feb 26 2021 | PANA | Nuvation Bio Inc. | Sharp Shalini | Director | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |